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Abstract
Objective : : To show transvaginal ultrasound accuracy 
in determining the degree of myometrial invasion of 
endometrial cancer within fi ve years in RSCM. Also, to 
know histopathology characteristics of endometrial cancer 
according to cell type, degree of invasion, and degree of 
differentiation of endometrial cancer, within the last fi ve 
years in RSCM.
Methods : This study is a cross-sectional study with a sample 
of 82 subjects in January 2011 – December 2016 at RSCM. 
The data were collected by total sampling from cancer 
registry Oncology and Gynaecology Division of Obstetrics 
and Gynecology FKUI-RSCM.
Results : Transvaginal USG diagnostic test in detection 
invasion has sensitivity, specifi city, PPV, and NPV as 78.79%, 
50%, 86.67%, 36.36% respectively. For determine degree of 
myometrial invasion it has sensitivity, specifi city, PPV, and 
NPV as 81.40%, 76.92%, 79.55%, and 78.90% respectively.
Conclusions : Transvaginal ultrasound has better accuracy in 
determining the degree of invasion compared to detecting 
myometrial invasion in endometrial cancer. In determining 
the degree of invasion, its sensitivity and specifi city are 81.4% 
and 76.92%. For detecting any invasion its sensitivity and 
specifi city was only 79.41% and 57.14%. Our study showed 
that transvaginal ultrasound was an effi cient diagnostic tool 
fo determine further treatment and prognosis in endometrial 
cancer.
Keywords : accuracy test, HPV DNA,  liquid-based cytology, 
pre-cervical cancer lesion.
Abstrak
Tujuan : Mengetahui akurasi USG transvaginal dalam 
menilai invasi miometrium pada kanker endometrium dalam 
5 tahun terakhir di RSCM. Serta karakteristik histopatologi 
berdasarkan tipe, invasi, dan derajat diferensiasi kanker 
endometrium dalam 5 tahun terakhir di RSCM.
Metode : Penelitian potong lintang dengan jumlah 
sampel 82 subjek pada Jan 2011 – Des 2016 di RSCM. Data 
dikumpulkan secara total sampling dari registrasi kanker 
Divisi Onkologi Ginekologi FKUI RSCM dan dilakukan uji 
diagnostik.
Hasil : Uji diagnostik USG transvaginal menilai ada tidaknya 
invasi memiliki sensitivitas, spesifi sitas, NPP, NPN sebesar 
78,79%, 50%, 86,67%, 36,36%. Sedangkan hasil uji diagnostik 
usg transvaginal dalam menilai derajat invasi memiliki 
sensitivitas, spesifi sitas, NPP, NPN sebesar 81,40%, 76,92%, 
79,55%, dan 78,90%.
Kesimpulan : USG transvaginal dalam menilai derajat invasi 
lebih baik dibanding menentukan ada tidaknya invasi. 
Sensitivitas, spesifi sitasnya 81,4% dan 76,92%  dibanding 
79,41% dan 57,14%. Dalam hal ini USG transvaginal 
dapat digunakan sebagai alat bantu diagnostik efi sien 
dalam menentukan tata laksana dan prognosis kanker 
endometrium.
Kata kunci : kanker endometrium, kedalaman invasi, uji 
diagnostik, USG transvaginal.
INTRODUCTION
Endometrial cancer is mostly suffered by 
postmenopausal women and in fourth place after 
breast, lung, and colon cancer. Endometrial cancer 
is the third most found cancer in Indonesia after 
cervical and ovarian cancer.1,2 Early detection is the 
determinant factor in endometrial cancer and can 
be done by taking endometrial samples  (biopsy 
and curettage) and imaging  examination.3
Endometrial cancer imaging has many 
modalities such as MRI, CT-Scan and 
Sonography. This imaging purpose is to evaluate 
the depth of invasion and to determine the 
prognosis of the disease. This can predict the 
lymphovascular metastases to determine the 
next operative management (surgical staging).4 
MRI is considered the best diagnostic tool yet 
expensive, which has 88-90% sensitivity, 84-88% 
specifi city and 86-90% accuracy in determining 
the degree of myometrium invasion.5-7Another 
modality is ultrasonography (USG) which is 
used in Indonesia because it is more applicable 
(cheaper and easier to use).2,8 In another study 
about USG, transvaginal USG (5-9MHz frequency) 
in determining endometrial cancer <50% and 
> 50% has 69% sensitivity and 79%, with 73% 
accuracy rate. Gordon, using 5 MHz probe USG 
with 25 samples showed 75% in specifi city 
and sensitivity, 76% accuracy.4 In developing 
countries like Indonesia, transvaginal USG is the 
main modality because it is cheaper and easier to 
use. Diagnostic value in USG to detect the degree 
of myometrial invasion is still little known.
To determine the transvaginal USG accuracy 
on assessing myometrium invasion in endometrial 
cancer cases at RSCM for the last fi ve years. This 
research is also to assess the characteristics such 
as demographic factor, the degree of myometrial 
invasion, cell type (histopathology) and the 
degree of differentiation in endometrial cancer 
cases.
METHOD
This research is using diagnostic study with 
2x2 table and cross-sectional study design. As 
an addition, descriptive research using cross-
sectional study will be used to determine the 
proportion of the type of cell (histopathology), 
the degree of invasion staging, and the degree 
of differentiation. The subjects of this study 
were registered patient with endometrial cancer 
which diagnosed within 1st January 2011 until 31st 
December 2016. Oncology division had the data 
written in the medical record at RSCM. Patients 
with other gynecology malignancy which did 
not perform hysterectomy were excluded 
from this research. The researcher took and 
specifi cally picked all the data from the medical 
record using inclusion and exclusion criteria. 
All the subjects were re-registered in research 
report form, including menopause status, 
parity, marital history, contraception history, 
and the degree of myometrial invasion based 
in preoperative transvaginal USG and post-
operation histopathology examination. The cell 
type and the stage of cancer differentiation will 
also be examined histopathologically after the 
operation. Patient with incomplete data will be 
tracked down.
All the histopathology data about myometrial 
invasion degree based on preoperative and 
postoperative transvaginal USG were input in 
the 2x2 table, using the diagnostic study. The 
data were inserted into Power and Sample 
Size Analysis (PASS) to determine the power 
and alpha value based on used samples. As an 
addition, proportion based on the degree of 
invasion, histopathology type and the degree of 
differentiation were calculated.
RESULT
There were 82 responders data obtained from the 
medical record based on cancer registry cases by 
RSCM Oncology Gynecology division from 2011-
2015, which exceeds from the research proposal’s 
sample with 70 samples. Samples were taken using 
total sampling method considering inclusion and 
criteria exclusion. The samples then examined 
for the degree of myometrial invasion based 
on medical record transvaginal USG data and 
compared it with the gold standard examination 
(histopathology).
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From 82 samples, endometrial cancer mostly 
found with myometrial invasion  > 50% based 
on histopathology examination. There were 43 
subjects (53,44%) with myometrial invasion  > 
50% and 23 (28,05%) with myometrial invasion 
< 50% and 16 (19,51%) with no myometrial 
invasion.
The most common type of endometrial cancer 
in the last 5 years in RSCM was endometrioid 
adenocarcinoma of 76 people (92.68%), the second 
most common type was clear cell carcinoma type 
which was found in 3 people (3.66%) and 3 other 
types with Endometrial Stromal Sarcoma (ESS) 
2 people (2.45%), and 1 person squamous cell 
carcinoma (1.22%). In the endometrial type was 
found to be a type of mucinosa in 1 patient and, 
adenosquamous in 4 patients. Types of serous 
papillary carcinomas are not found in this study.
Based on the degree of differentiation of G1 
as many as 31 people (37.8%), G2 as many as 
33 people (40.24%), G3 as many as 13 people 
(15.85%) and fi ve other respondents with an 
unknown degree of differentiation (6.1%).
Based on table 2 the characteristics of 
histopathology examination results based on the 
depth of invasion in RSCM which found mostly 
was endometrial cancer with depth of invasion > 
50% as much as 53.44% and patients with depth 
of invasion <50% as much as 28.05%, while there 
was without invasion as much as 19.51%. The 
type of endometrial cancer in the last 5 years 
at RSCM was the most 92.68% endometrioid 
adenocarcinoma type, the second type of clear 
cell type was 3.66% and the other 3 respondents 
were Endometrial Stromal Sarcoma (ESS) 2 people 
(2.45%), and 1 person squamous cell carcinoma 
(1.22%). Based on the degree of differentiation 
of G1 as many as 31 people (37.8%), G2 as many 
as 33 people (40.24%), G3 as many as 13 people 
(15.85%) and fi ve other respondents unknown 
degree of differentiation (6.1%).
Table 1. Demographic characteristics
n (%)Characteristics
Age (mean ± SD)
Menopausal age (mean ± SD) 
Parity status
Nullipara
Primipara
Multipara
Grande multipara
Menopausal status
Pre Menopause
Post Menopause
Contraception history
Pill
Injection
IUD
Implant
Not using any contraceptive method   
53.37 ± 11.33
50.14 ±   5.50
26 (31.7)
14 (17)
32 (39)
10 (12.3)
36 (43.9)
46 (56.1)
7 (8.53)
3 (3.65)
8 (9.76)
0
64 (78.06)
Table 2. Histopathology Characteristic
n (%)Characteristics
Degree of Invasion 
Without Invasion
< 50%
>50%
Histopathology Type
Endometrioid Adenocarcinoma
Papillary Serous Carcinoma
Clear Cell Carcinoma 
Others
Endometrial Stromal Sarcoma (ESS)
Squamous Cell Carcinoma
Degree of Differentiation  
G1                                                                                                             
G2
G3
Unknown (Gx)
Total
16
23
43
76
0
3
3
2
1
31
33
13
5
82
19.51
28.05
52.44
92.68
0
3.66
3.66
2.45
1.22
37.80
40.24
15.85
6.10
100
Table 3. Diagnostic Value of Transvaginal Ultrasound 
to determine the Presence of Myometrial Invasion in 
Endometrial Cancer cases
Table 4. Diagnostic Value of Transvaginal Ultrasound 
in todetermine theDegree of Myometrial Invasion in 
Endometrial Cancer cases
Ultrasound Degree of 
Invasion(pre-operative)
The Degree of 
Invasion based on 
USG examination 
(Preoperative) (%)
Histopathology Invasion (Postoperative)
Histopathology Invasion (Postoperative)
Presence
>50%
Absence
<50%
Total
Total
Presence
Absence
>50
<50
35
8
9
30
44
38
Sensitivity
Specifi city
Positive Predictive Value
Negative Predictive Value
Positive Possibility Ratio
Negative Possibility Ratio
: 78.79 % (95% CI 66.98– 87.89%)
: 50 % (95% CI 24.65 – 75.35 %)
: 86.67 % (95% CI 79.67– 91.51%)
: 36.36 % (95% CI 22.53 – 52.89 %)
: 1.58 (95% CI 0.95 – 2.61) 
: 0.42 (95% CI 0.22 – 0.83)
Total
Total
8   
8
16
39
52
14
66
43
 60
 22
82
82
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Sensitivity
Specifi city
Positive Predictive Value
Negative Predictive Value
Positive Possibility Ratio
Negative Possibility Ratio
: 81.40 % (95% CI 66.60– 91.61 %)
: 76.92 % (95% CI 60.67 – 88.87 %)
: 79.55% (95% CI 68.30– 87.53%)
: 78.95 % (95% CI 66.23 – 87.76%)
: 3.53 (95%CI 1.95 – 6.37) 
: 0.24 (95% CI 0.13 – 0.46)
DISCUSSION
This study managed to get a total of 82 subjects. 
Based on our medical records on patients 
who have radiation or chemotherapy outside, 
with other gynecological malignancies, or no 
hysterectomy before which was not included 
in this study because it may affect the result 
of examinations. For transvaginal ultrasound 
examinations used in this study is Voluson E8 
with transvaginal probes EC4-9ES with 4-9 MHz 
frequency The result of ultrasound examinations 
in this study can be considered valid if the USG 
tools were calibrated every year and used by 
experts who are competent in their fi eld.
Based on menopausal status, endometrial 
cancer more likely found in menopause age (56.1%) 
compared to premenopause (43.9%). Based on 
demographic data that we obtained in this study 
showed that the mean age of endometrial cancer 
diagnosis at RSCM was 53 years, and menopause 
means age was 50 years. When viewed based 
on menopausal status, endometrial cancer more 
common in menopausal age patient (56.1%) 
than pre-menopause (43.9%). We obtained 
menopausal age same as mean menopausal age 
based on BKKBN data in 2015 that is 50 years. 
This different from SOGC data in 2013, which only 
10-15% cases of endometrial cancer are found at 
premenopause age. This difference may be due to 
we do not control the risk factor, such as BMI and 
lifestyle, history of patient illness that may be a 
risk factor for endometrial cancer such as PCOS.3,4 
Our data showed multiparous patient had more 
than nulliparas because we do not seek another 
risk factor in these multipara patients and for two 
to four parity grouped as multiparous.
Other demographic data on contraceptive 
use in accordance with studies that stated 
contraceptive use decreases estrogen exposure 
and increases progesterone levels in women and 
has a protection effect.9,10Most of endometrial 
cancer cases found in subjects without history of 
contraception used 78.06% and  least in women 
with a family history of hormonal contraceptives 
(8.53% pill or injection 3.65%). This study did not 
seek further effects of these risk factors on the 
endometrial cancer incidence, but only provides 
an overview of the spread of risk factors.
Based on the cancer register study in the last 
fi ve years at RSCM, most cases were invasive. 
There were 52.44% cases with the invasion 
to endometrium depth >50%, 28.04% cases 
with  <50% endometrium invasion and 19.51% 
cases with no invasion. Although most cases 
are endometrioid types with slow progress than 
other types of endometrial cancers, most fi nding, 
in this case, involves more than 50% of invasion. 
Like wise, in the degree of differentiation, G1 is 
more commonly found with less than one third 
of invasion in the myometrium.10 This may be 
due to the late diagnosis of endometrial cancer, 
which may be infl uenced by factors that will not 
be discussed further.
Based on cancer type, the incidence of 
endometrial cancer type 1 or endometrioid 
estrogen dependent is in the fi rst place (92.68%). 
The second most common type is the clear cell 
type of 3.66%. Based on this study, no serous 
papilosa type was found in endometrial cancer 
patients at RSCM in the last fi ve years.
The data is slightly different from the study in 
Turkey who acquired the endometrioid type as 
much as 87%, while the other type that is found 
is papillary serosa carcinoma of 7% not found 
in the last fi ve years study data at RSCM. In the 
previous study, the percentage of clear cell types 
was not much different from the data we got as 
much as 2%. Histopathological study data from 
432 patients in the Netherlands in 2013 showed 
the highest non endometrioid type was 7.6% 
paposa serosa not found in RSCM, in which case 
the possibility of races affected the incidence 
of this cancer.11 More than 85% of endometrial 
cancers are endometrioid types of estrogen 
dependent. Risk factors for this type are long-
term estrogen exposures.9 Long-term estrogen 
exposure is also consistent with the fi ndings of 
most endometrial cancer at menopause as much 
as 56.10% compared with premenopause.9
Based on the data, the endometrioid type for 
G1, G2 and G3 are 26%, 28%, and 10% from all 
cases. There was no estrogen receptor with a 
high differentiated degree and advanced stage 
on clear cell type. This data was fi t with this study, 
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which showed only G3 differentiation staging and 
undifferentiated cases. ESS incidence was 1% and 
based on the histopathogenesis, long exposure 
estrogen and PCOS can not be conclusive to defi ne 
as a risk factor for ESS. Undifferentiated cases on 
this tumor were not based on mitosis phase but 
based on pleomorfi sm and core necrosis. This 
statement fi ts with ESS characteristics in another 
study which had 2 subjects with undifferentiated 
stage ESS (Gx). Most of the endometrioid cases 
were found with stage 1 and 2 differentiation 
which had a good prognosis.12
The main objective of this study is to obtain the 
diagnostic value of transvaginal ultrasonography 
and to obtain sensitivity, specifi city, positive 
predictive value, the negative predictive value of 
transvaginal ultrasound are 78.79%, 50%, 86.67% 
and 36.36%. Most of the studies which we found, 
did not differentiate between invasive fi ndings 
and less than half of myometrium because of the 
risk of lymph nodes involvement was considered 
to be the same and did not affect the staging 
and management.13 However, in the case of 
no myometrial invasion there was no pelvic 
lymph node metastase, whereas in the case of 
myometrial invasion although less than one-third 
of myometrial thickness, there were 3-9% pelvic 
lymph node metastases.9 In addition, it affects 
the incidence of distant metastases. In patients 
who did not undergo a myometrial invasion, only 
4.3% whereas if the invasion was found <50% 
the depth of myometrium is 10-11%. In this 
case, invasion fi nding although <50% based on 
transvaginal ultrasound may be considered for 
screening for distant metastases and operator 
accuracy in assessing intraoperative lymph node 
spreading.
Transvaginal ultrasound in assessing the 
myometrial depth of invasion >50% has 
sensitivity, specifi city, positive predictive value, 
negative predictive value, and accuracy 81.40%, 
76.92%, 79.55%. moreover, 82.69%. Based 
on the meta-analysis in 2014, the sensitivity 
and specifi city og transvaginal ultrasound in 
assessing the depth of invasion is 82% and 81%. 
The different diagnostic value may be due to 
fewer sample sizes or due to the differences of 
endometrial depth measurement techniques 
with transvaginal ultrasound in ultrasonogrpaher 
that is different from each other in this study and 
previous studies.13
Our study shows that ultrasound can be a 
screening tool to see the invasion, because of its 
good sensitivity, but insignifi cant in determining 
the stage and prognosis. Based on this result, the 
use of transvaginal ultrasound can not be the 
only option to select the extensive candidate of 
operative patients.
In using transvaginal ultrasound, it is necessary 
to note the risk factors, type, and stage of invasion 
to be a diagnostic tool in determining the next 
procedure and patient prognosis.
The use of transvaginal ultrasound in assessing 
the stage of invasion can be a good and effi cient 
diagnostic tool in preoperative assessment. 
However, the assessment of depth of invasion 
can nto be sparated from the assessment of 
the type of cancer and degree of differentiation 
in determining stage and prognosis. The 
disadvantage of this study is the incompleteness 
of medical record that allows for exclusion criteria 
of circumstances that allow for the occurrence 
of a false negative number that will affect the 
sensitivity and false positive numbers that will 
affect the specifi city number. The absence of 
control throughout the preoperative assessment 
of transvaginal ultrasound by operative 
hysterectomy became the weakness of this study. 
In addition, Kappa test control is not performed 
to see the equivalence of ultrasound operators, 
whereas ultrasound diagnostic tools are highly 
operator dependent.
CONCLUSION
The accuracy of transvaginal ultrasound obtained 
from this study is not much different from other 
studies conducted in other countries. However, 
in this study obtained ultrasound accuracy in 
assessing the depth of invasion of endometrial 
cancer is better than determining the presence 
or absence of invasion. In this case, transvaginal 
ultrasound can be used as an effi cient diagnostic 
tool in determining the management and 
prognosis of endometrial cancer. Based on the 
invasion of the incidence of endometrial cancer 
with invasion>50% is the most found in RSCM 
in 2011-2016 as much as 52.44%. Based on the 
type of histopathology, the most incidence of 
endometrial cancer is endometrioid type as much 
as 92.68%. Based on the degree of differentiation 
of the incidence of endometrial cancer in RSCM 
is G2 of 40.24%.
This cross-sectional study with a limited 
sample needs to be considered for further 
research, especially by performing a transvaginal 
ultrasound equivalent examination in assessing 
invasion by the same expert to avoid any bias 
between examiners. Moreover, as a transvaginal 
ultrasound diagnostic tool in assessing the depth 
of invasion needs to be combined with fi ndings of 
differentiation and cell type degrees to determine 
prognosis.
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